Community/Retail

Injuries from electronic cigarettes (e-cigarettes) are on the rise, which may pose a significant public health threat.

With the entrance of pharmacist requirements on some states' cannabis legislation, our health profession is obligated to keep an open mind toward the subject.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can't miss for the busy pharmacy professional.

One worry that many pharmacy students have when they get out of school concerns how to tell a physician that a mistake's been made with a medication dose or frequency and then how to explain the right course of action.

The FDA recently approved Janssen's ustekinumab (Stelara) for the treatment of moderate to severe active Crohn's disease in adults who have failed or were intolerant to treatment with immunomodulators or corticosteroids but never failed treatment with a tumor necrosis factor (TNF) blocker, as well as those who failed or were intolerant to treatment with one or more TNF blockers.

The U.S. Pharmacopeial Convention (USP) has posted for public comment its recommended revisions to the USP Medicare Model Guidelines (USP MMG) " a classification system that supports formulary development for medications covered under Medicare Part D benefits